Introduction: The wholesale FOXO4 DRI peptide selectively induces apoptosis in senescent cells by disrupting FOXO4-p53 binding, offering secure, substantial-purity materials for growing older and most cancers research. Daily laboratory workflows generally reveal a persistent problem: the slow and inefficient removal of senescent cells that impair